First prospective European study for the feasibility and safety of magnetically controlled capsule endoscopy in gastric mucosal abnormalities

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 20

Peer-Review Report of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. May 28, 2022; 28(20): 2227-2242
Published online May 28, 2022. doi: 10.3748/wjg.v28.i20.2227

Table 5 Distribution of pathologies detected by magnetically controlled capsule endoscopy

	Polyp ventriculi	Ulcus ventriculi	Coeliakia	Crohn	Gastritis	Small intestinal diverticula	Angiodysplasia	Aspecific infalmmation in small bowel
Major pathologies	5	9	1	23	159	1	26	9

Citation: Szalai M, Helle K, Lovász BD, Finta Á, Rosztóczy A, Oczella L, Madácsy L. First prospective European study for the feasibility and safety of magnetically controlled capsule endoscopy in gastric mucosal abnormalities. World J Gastroenterol 2022; 28(20): 2227-2242
URL: https://www.wjgnet.com/1007-9327/full/v28/i20/2227.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i20.2227

Szalai M, Helle K, Lovász BD, Finta Á, Rosztóczy A, Oczella L, Madácsy L. First prospective European study for the feasibility and safety of magnetically controlled capsule endoscopy in gastric mucosal abnormalities. World J Gastroenterol 2022; 28(20): 2227-2242 [PMID: 35721886 DOI: 10.3748/wjg.v28.i20.2227]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.